Pravastatin inhibits C-reactive protein generation induced by fibrinogen, fibrin and FDP in isolated rat vascular smooth muscle cells
Authors:
- 17 November 2011
- journal article
- research article
- Published by Springer Nature in Inflammation Research
- Vol. 61 (2) , 127-134
Abstract
Objective The available evidence indicates that C-reactive protein (CRP) participates directly in atherosclerosis formation as an inflammatory molecule. Our previous investigation suggested that fibrinogen, fibrin and fibrinogen degradation products (FDP) produce a pro-inflammatory effect on vascular smooth muscle cells (VSMCs) through inducing CRP generation. In the present study, we observed the effect of pravastatin on CRP generation induced by fibrinogen, fibrin and FDP in rat VSMCs. Methods VSMCs from Sprague-Dawley rats were cultured. Fibrinogen, fibrin and FDP were used as stimulants for CRP generation. VSMCs were preincubated with pravastatin at 10, 30, 100 μM for 30 min prior to stimulation. CRP mRNA expression was studied by reverse transcription polymerase chain reaction (RT-PCR). CRP levels in the supernatant of VSMCs were measured by enzyme-linked immunosorbent assay (ELISA). CRP expression in VSMCs was examined with immunocytochemical staining. Results ELISA analysis showed that the pravastatin concentration-dependently reduced fibrinogen-, fibrin- and FDP-stimulated generation of CRP in VSMCs, with maximal inhibition of 56.6, 55.7 and 62.3%, respectively. Immunocytochemical staining and RT-PCR revealed that pravastatin inhibited protein and mRNA expression of CRP in VSMCs significantly. Conclusions Pravastatin at the concentrations used in the present experiment has ability to relieve vascular inflammation and to restrain atherosclerotic processes via inhibiting the CRP production induced by fibrinogen, fibrin and FDP in VSMCs, which helps explain the beneficial effects of pravastatin on atherosclerosis.Keywords
This publication has 25 references indexed in Scilit:
- Elevated fibrinogen levels and subsequent subclinical atherosclerosis: The CARDIA StudyAtherosclerosis, 2009
- Human C-reactive protein promotes oxidized low density lipoprotein uptake and matrix metalloproteinase-9 release in Wistar ratsJournal of Lipid Research, 2008
- Effect of Withdrawal of Pravastatin Therapy on C-Reactive Protein and Low-Density Lipoprotein CholesterolThe American Journal of Cardiology, 2007
- Inflammation, Atherosclerosis, and Coronary Artery DiseaseNew England Journal of Medicine, 2005
- C-Reactive Protein Enhances LOX-1 Expression in Human Aortic Endothelial CellsCirculation Research, 2004
- C-Reactive Protein Upregulates Angiotensin Type 1 Receptors in Vascular Smooth MuscleCirculation, 2003
- Coagulation Pathways in AtherothrombosisTrends in Cardiovascular Medicine, 2002
- FibrinogenThe International Journal of Biochemistry & Cell Biology, 1999
- Enhancement of Interleukin‐6 Production by Fibrinogen Degradation Product D in Human Peripheral Monocytes and Perfused Murine LiverScandinavian Journal of Immunology, 1995
- Abnormalities in growth characteristics of aortic smooth muscle cells in spontaneously hypertensive rats.Hypertension, 1989